CRWV insider sale filing: 311,796 Class A shares via J.P. Morgan

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filed a Form 144 disclosing a proposed sale of 311,796 shares of Class A common stock through J.P. Morgan Securities with an aggregate market value of $28,495,036. The filing lists the approximate date of sale as 08/27/2025 and reports 370,470,348 shares outstanding for the class.

The shares were largely acquired through recent equity events: RSU vesting on 05/20/2025 (2,127 shares) and 08/20/2025 (2,056 shares), and a stock option exercise on 08/27/2025 for 307,613 shares paid in cash. The filing also notes a prior sale on 08/20/2025 of 2,292 shares for gross proceeds of $206,215.

Positive

• Required disclosure provided via Form 144, increasing transparency about insider selling plans
• Major broker engaged (J.P. Morgan Securities), which suggests orderly handling of the sale
• Shares originated from compensation (RSU vesting and option exercise), indicating scheduled liquidity rather than divestiture of long-held shares

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider plans to sell 311,796 CRWV shares; size is small relative to outstanding shares, suggesting limited market impact.

The proposed sale of 311,796 shares equals roughly 0.08% of the reported 370.5 million Class A shares outstanding, indicating the transaction is unlikely to materially affect market supply or company valuation. The timing and source—primarily a large option exercise on the same date—suggest this is a monetization of recently vested/elected equity rather than a sale of long-held holdings. Disclosure via Form 144 and use of a major broker (J.P. Morgan) follow standard insider-sale procedures, providing transparency for investors.

Corporate Governance Expert

TL;DR: Form 144 filing shows compliant insider disclosure; no red flags in paperwork or aggregation of recent sales.

The filing documents acquisitions through RSU vesting and option exercise, and reports a recent small sale on 08/20/2025. The notice contains the customary representation about material nonpublic information and identifies a clearing broker. There is no evidence in this filing of clustered or unusually large disposals that would prompt governance concerns. From a compliance perspective, the disclosure is complete for the scheduled sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	J.P. Morgan Securities LLC 390 Madison Avenue - 6th Floor New York NY 10017	311796	28495036	370470348	08/27/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	05/20/2025	RSU Vesting	Issuer			2127	05/20/2025	Compensation
Class A Common Stock	08/20/2025	RSU Vesting	Issuer			2056	08/20/2025	Compensation
Class A Common Stock	08/27/2025	Stock Option Exercise	Issuer			307613	08/27/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kristen J. McVeety C/o CoreWeave, Inc. 290 West Mt. Pleasant Avenue, Suite 4100 Livingston NJ 07039	Class A Common Stock	08/20/2025	2292	206215

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CoreWeave's (CRWV) Form 144 disclose?

The Form 144 discloses a proposed sale of 311,796 Class A shares through J.P. Morgan with aggregate market value $28,495,036, dated 08/27/2025.

How many CoreWeave shares are outstanding per the filing?

The filing reports 370,470,348 Class A shares outstanding.

How were the shares to be sold acquired?

Shares were acquired via RSU vesting on 05/20/2025 (2,127) and 08/20/2025 (2,056), and a stock option exercise on 08/27/2025 (307,613) paid in cash.

Did the filer recently sell any CRWV shares?

Yes. The filing reports a sale on 08/20/2025 of 2,292 shares for gross proceeds of $206,215 by Kristen J. McVeety.

Through which broker will the sale be executed?

The proposed sale is to be executed through J.P. Morgan Securities LLC.